baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

BRISTOL-MYERS SQUIBBDL-10/ US1101221083 /

1/24/2025 3:42:20 PM	Chg. -0.130	Volume	Bid3:42:20 PM	Ask3:42:20 PM	Market Capitalization	Dividend Y.	P/E Ratio
56.580EUR	-0.23%	- Turnover: -	56.580Bid Size: -	56.650Ask Size: -	115.89 bill.EUR	-	-

TeleTrader 11/11/2024 US closes mostly higher ahead of inflation data

TeleTrader 11/11/2024 Dow gains 330 points at open after record week

GlobeNewswire 9/3/2024 Amphista Therapeutics appoints Antony Mattessich as Chief Executive Officer

GlobeNewswire 9/2/2024 CSE Announces its 2024 Sustainability & ESG Leadership Summit at NYC's One World Trade Center

GlobeNewswire 8/30/2024 Purple Biotech to Participate at H.C. Wainwright 26th Annual Global Investment Conference

GlobeNewswire 8/29/2024 Immunocore announces transition of Chief Financial Officer

GlobeNewswire 8/28/2024 Hematologists Highlight Ongoing Challenges in Sickle Cell Disease and Thalassemia Amidst Promising A...

GlobeNewswire 8/22/2024 Abata Therapeutics Receives FDA Fast Track Designation for ABA-101 for the Treatment of Progressive ...

GlobeNewswire 8/15/2024 Abata Therapeutics Announces Strategic Investment from Bristol Myers Squibb Supporting Advancement o...

GlobeNewswire 8/12/2024 Altamira Therapeutics Announces Significant Enhancement of Immune Checkpoint Inhibition Therapy in C...

Newsfile Corp 8/12/2024 The Cancer Battle - How Smaller Companies Are Making Big Advancements in Treatments for Solid Tumors

GlobeNewswire 8/12/2024 Caribou Biosciences Appoints Tina Albertson, MD, PhD, as Chief Medical Officer

GlobeNewswire 8/8/2024 CytomX Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire 8/7/2024 Efficacy and Safety Data of Sotagliflozin in Patients with Type 1 Diabetes and Chronic Kidney Diseas...

GlobeNewswire 8/6/2024 ALX Oncology Appoints Alan Sandler, M.D., to Board of Directors

GlobeNewswire 8/5/2024 iTeos Therapeutics Announces Appointment of David Feltquate as Chief Medical Officer

GlobeNewswire 8/1/2024 Outpace Bio Announces $144M Oversubscribed Series B Financing to Advance AI-powered Cell Therapies i...

GlobeNewswire 8/1/2024 CytomX Therapeutics to Report Second Quarter 2024 Financial Results on August 8, 2024

GlobeNewswire 7/31/2024 Mural Oncology Appoints Veteran Business Development Executive George Golumbeski, Ph.D., to its Boar...

GlobeNewswire 7/30/2024 Anaveon appoints Dieter Weinand as Chair of its Board of Directors

GlobeNewswire 7/25/2024 Purple Biotech Receives Extension to Regain Compliance with the Nasdaq’s Minimum Bid Price Rule

GlobeNewswire 7/24/2024 Prota Therapeutics Strengthens Board with Appointment of Global Biotech Expert Patrick Machado

GlobeNewswire 7/20/2024 NCLA Asks Third Circuit to Rule Against HHS’s Coercive Medicare Drug Price ‘Negotiation’ Program

GlobeNewswire 7/17/2024 Nouscom Appoints Tiffany Muller as Chief Financial Officer and Loredana Siani as Senior Vice Preside...

GlobeNewswire 7/9/2024 VYNE Therapeutics Announces Appointment of Subhashis Banerjee, M.D. as Senior Vice President of Clin...

BRISTOL-MYERS SQUIBBDL-10/ US1101221083 /

If you wish to receive reply to your feedback, please provide your email address.